Tag: Non pharmacological treatments

According to the FDA, in May 2023, brexpiprazole (Rexulti) became the first and only medication specifically approved to treat agitation associated with dementia due to Alzheimer's disease. Choosing **what medication is used for senile agitation** is complex, requiring careful consideration of risks and the significant benefits of non-pharmacological interventions.

Over 90% of people with dementia experience behavioral and psychological symptoms (BPSD), such as agitation, aggression, and mood swings. Addressing these challenging symptoms is crucial for quality of life, yet identifying **what is the best mood stabilizer for dementia patients?** involves a careful balance of potential benefits and significant risks. A comprehensive and individualized approach, starting with non-pharmacological interventions, is universally recommended before considering medication.